Cargando…

Prevalence of Germline BRCA1/2 Variants in Ashkenazi and Non-Ashkenazi Prostate Cancer Populations: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Germline BRCA2 pathogenic variant carriers are associated with prostate cancer risk. Ashkenazi Jewish people are at higher risk of breast cancer due to the high prevalence of specific founder germline BRCA1/2 variants. The distribution of these variants (BRCA1 vs. BRCA2) in Ashkenazi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cioffi, Antonio, De Cobelli, Ottavio, Veronesi, Paolo, La Vecchia, Carlo, Maisonneuve, Patrick, Corso, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818251/ https://www.ncbi.nlm.nih.gov/pubmed/36612302 http://dx.doi.org/10.3390/cancers15010306

Ejemplares similares

Genetic architecture of prostate cancer in the Ashkenazi Jewish population
por: Vijai, J, et al.
Publicado: (2011)

Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
por: Hamel, Nancy, et al.
Publicado: (2003)

Population‐based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants
por: Castillo, Cecilia, et al.
Publicado: (2022)

Case report: BRCA in the Ashkenazi population: are current testing guidelines too exclusive?
por: Saunders, Katherine H, et al.
Publicado: (2011)

The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients
por: Chen-Shtoyerman, R, et al.
Publicado: (2001)

Carrier screening in individuals of Ashkenazi Jewish descent
por: Gross, Susan J., et al.
Publicado: (2008)

Assembly and annotation of an Ashkenazi human reference genome
por: Shumate, Alaina, et al.
Publicado: (2020)

BRCA1 and BRCA2 Mutations Other Than the Founder Alleles Among Ashkenazi Jewish in the Population of Argentina
por: Solano, Angela R., et al.
Publicado: (2018)

Differences in MS clinical and epidemiological characteristics between Ashkenazi and non-Ashkenazi Jewish patients in Israel: a retrospective single center study
por: Karni, Arnon, et al.
Publicado: (2022)

Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry
por: Tennen, Ruth I., et al.
Publicado: (2020)

High mammographic density in women of Ashkenazi Jewish descent
por: Caswell, Jennifer L, et al.
Publicado: (2013)

The time and place of European admixture in Ashkenazi Jewish history
por: Xue, James, et al.
Publicado: (2017)

Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review
por: Corso, Giovanni, et al.
Publicado: (2021)

Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry
por: Wang, Zhaoming, et al.
Publicado: (2012)

Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians
por: Hannah-Shmouni, Fady, et al.
Publicado: (2017)

Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.
por: Lehrer, S., et al.
Publicado: (1998)

Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled Trial
por: Manchanda, Ranjit, et al.
Publicado: (2014)

Implications for health and disease in the genetic signature of the Ashkenazi Jewish population
por: Guha, Saurav, et al.
Publicado: (2012)

Genetic contribution to multiple sclerosis risk among Ashkenazi Jews
por: Khankhanian, Pouya, et al.
Publicado: (2015)

An identical novel mutation in BRCA1 and a common haplotype in familial ovarian cancer in non-Ashkenazi Jews.
por: Theodor, L., et al.
Publicado: (1998)

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing
por: Manchanda, Ranjit, et al.
Publicado: (2014)

Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes
por: Burnell, Matthew, et al.
Publicado: (2022)

No association between germline allele-specific expression of TGFBR1 and colorectal cancer risk in Caucasian and Ashkenazi populations
por: Seguí, N, et al.
Publicado: (2011)

Real World Cost-Effectiveness Analysis of Population Screening for BRCA Variants among Ashkenazi Jews Compared with Family History-Based Strategies
por: Michaelson-Cohen, Rachel, et al.
Publicado: (2022)

Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping
por: Olshen, Adam B, et al.
Publicado: (2008)

Identifying high-impact variants and genes in exomes of Ashkenazi Jewish inflammatory bowel disease patients
por: Wu, Yiming, et al.
Publicado: (2023)

Prevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern Brazil
por: Dillenburg, Crisle Vignol, et al.
Publicado: (2012)

Ashkenazi Jewish Centenarians Do Not Demonstrate Enrichment in Mitochondrial Haplogroup J
por: Shlush, Liran I., et al.
Publicado: (2008)

A substantial prehistoric European ancestry amongst Ashkenazi maternal lineages
por: Costa, Marta D., et al.
Publicado: (2013)

Genetic Complexity of Crohn’s Disease in Two Large Ashkenazi Jewish Families
por: Levine, Adam P., et al.
Publicado: (2016)

Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population
por: Rivas, Manuel A., et al.
Publicado: (2018)

Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk
por: Hamada, Tsuyoshi, et al.
Publicado: (2019)

Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)
por: Apicella, Carmel, et al.
Publicado: (2003)

Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease
por: Schiff, E. R., et al.
Publicado: (2018)

Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women
por: Hardy, Melanie W., et al.
Publicado: (2022)

BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored
por: Crocetto, Felice, et al.
Publicado: (2021)

How old is this mutation? - a study of three Ashkenazi Jewish founder mutations
por: Greenwood, Celia MT, et al.
Publicado: (2010)

Ashkenazi Jewish Origin Protects Against Formation of Antibodies to Infliximab and Therapy Failure
por: Ungar, Bella, et al.
Publicado: (2015)

Correction: Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population
por: Rivas, Manuel A., et al.
Publicado: (2019)

A collaborative genetic carrier screening model for the British Ashkenazi Jewish community
por: Ziff, Monica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3fuisdcmc4cg6btqqcm2euilrk